SCHEMBL29929637

SCHEMBL29929637

NNc1ncc2c(n1)-c1ccccc1CC2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.66
CYP3A4 P08684 4/20 0.66
GAA P10253 4/20 0.66
CYP2C19 P33261 3/20 0.66
KDM4E B2RXH2 9/20 0.64
ALDH1A1 P00352 7/20 0.64
POLB P06746 3/20 0.64
LMNA P02545 3/20 0.63
HTT P42858 4/20 0.60
CYP2C9 P11712 2/20 0.60
IKBKB O14920 2/20 0.60
CYP2D6 P10635 1/20 0.60
MAPT P10636 5/20 0.55
HPGD P15428 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
KPNA2 P52292 1/20 0.55
CCNA2 P20248 3/20 0.50
CDK2 P24941 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4986074 1.00 CYP1A2 (0.66) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL12330249 0.84 CYP1A2 (0.62) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL2434868 0.81 CDK2 (0.74) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL13373267 0.80 CYP1A2 (0.58) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL5472904 0.80 CYP1A2 (1.00) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL4990063 0.78 KDM4E (1.00) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL29929816 0.78 KDM4E (1.00) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL11296578 0.78 LMNA (1.00) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL11296744 0.76 IKBKB (0.73) CYP1A2CYP3A4GAACYP2C19KDM4E
SCHEMBL5469070 0.76 KDM4E (1.00) CYP1A2CYP3A4GAACYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110551105-B Substituted triazoles useful as AXL inhibitors 里格尔制药公司 2022-10-18 CN disclosed